News
Sézary syndrome represents a type of blood malignancy ... Laboratory test to assess a complete blood count is initially performed. Peripheral blood smear, immunophenotyping, T-cell receptor ...
The standardization of a sensitive ELISA for the quantification of SHP-1 protein in peripheral T and B lymphocytes ... T cells from patients with Sezary syndrome and in the Sezary T cell line ...
Sézary syndrome. KIR3DL2 is expressed in up to 50% of patients with mycosis fungoides and peripheral T-cell lymphoma (PTCL). It has a restricted expression on normal tissues. Lacutamab has been ...
The classical forms of CTCL are plaque-type mycosis fungoides (MF) and Sezary syndrome (SS). SS is a rare, leukemic variant of CTCL that typically presents with erythroderma, peripheral ...
Sézary syndrome. It is expressed by up to 50% of patients with mycosis fungoides and peripheral T-cell lymphoma (PTCL). It has a restricted expression on normal tissues. Lacutamab is granted ...
in particular Sézary syndrome. It is expressed by up to 50% of patients with mycosis fungoides and peripheral T-cell lymphoma (PTCL). It has a restricted expression on normal tissues. Cohort 1 ...
Long term follow-up data from the TELLOMAK Phase 2 trial in Sézary syndrome (SS ... in combination with other anti-lymphoma agents in peripheral T-cell lymphomas (PTCL).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results